Latest | Instant Finance & Market News_第97页 | NewTimeSpace

09:12

[ ProteLight files for HKEX listing with world's first NDA-approved FIC gana-based drug ] NewTimeSpace News: On 31 August 2026, ProteLight Pharmaceuticals (Jiangsu) Co., Ltd. filed its listing application with HKEX, with CITIC Securities as the sole sponsor; its core product PL-5 is the world's first NDA-approved first-in-class gana-based drug, having received NMPA approval in June 2026 for the treatment of secondary infections of burn wounds, with plans to expand into indications including diabetic foot infections.

Tag： ProteLight IPO file a listing application

09:07

[ VONGROUP (00318.HK): FY2026 results expected before mid-September, trading remains suspended ] NewTimeSpace News: On 31 August 2026, VONGROUP (00318.HK) announced that its FY2026 annual results are expected to be published before mid-September 2026, with the despatch of the annual report delayed accordingly; trading in its shares has been suspended since 3 August and will remain suspended until the annual results are published.

Tag： VONGROUP 00318.HK Delay

09:05

[ BIDU-SW (09888.HK): Conversion to dual-primary listing takes effect, HK shares and ADSs remain interchangeable ] NewTimeSpace News: On 1 September 2026, BIDU-SW (09888.HK) announced that the conversion of its voluntary change from secondary listing to dual-primary listing has taken effect, with the Company now dual-primary listed on the Hong Kong Stock Exchange and the Nasdaq Global Select Market, and its ordinary shares and ADSs remain interchangeable.

Tag： BIDU-SW 09888.HK dual-primary listing

09:04

[ LAEKNA-B (02105.HK): First subject enrolled in Phase I clinical study of LAE118 for advanced solid tumours ] NewTimeSpace News: On 1 September 2026, LAEKNA-B (02105.HK) announced that the first subject has been enrolled in the Phase I clinical study of LAE118, a novel PI3Kα pan-mutation selective inhibitor, for advanced solid tumours in China; the drug has received IND approval from the US FDA and CDE, and in June 2026 the Group entered into an exclusive licence agreement with Vasque Bio providing for payments of up to USD 527 million.

Tag： LAEKNA-B 02105.HK Clinical Trial

09:02

[ ASCLETIS-B(01672.HK)2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 319.67 million, loss widened by 263.46% YoY ] NewTimeSpace (newtimespace.com) News, August 31, 2026, ASCLETIS-B(01672.HK) released its Interim Report for the period ended December 31, 2026

Tag： ASCLETIS-B 01672.HK NewTimeSpace

09:02

[ VENUS MEDTECH-B(02500.HK)2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 191.31 million, loss widened by 41.95% YoY ] NewTimeSpace (newtimespace.com) News, August 31, 2026, VENUS MEDTECH-B(02500.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 135.5 million, decreased by 27.59% YoY

Tag： VENUS MEDTECH-B 02500.HK NewTimeSpace

09:02

[ WK GROUP(02535.HK)2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 11.52 million, turned into a loss from a profit YoY ] NewTimeSpace (newtimespace.com) News,August 31, 2026, WK GROUP(02535.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 87.76 million, decreased by 46.98% YoY

Tag： WK GROUP 02535.HK NewTimeSpace

09:02

[ AGILE GROUP(03383.HK)2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 8.83 billion, loss widened by 9.96% YoY ] NewTimeSpace (newtimespace.com) News, August 31, 2026, AGILE GROUP(03383.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 10.86 billion, decreased by 19.99% YoY

Tag： AGILE GROUP 03383.HK NewTimeSpace

09:02

[ CLOUDBREAK-B(02592.HK)2026 Interim Report - Profit Attributable to Shareholders stood at loss of USD 47.95 million, turned into a loss from a profit YoY ] NewTimeSpace (newtimespace.com) News, August 31, 2026, CLOUDBREAK-B(02592.HK) released its Interim Report for the period ended December 31, 2026

Tag： CLOUDBREAK-B 02592.HK NewTimeSpace

09:02

[ GOLDEN THROAT(06896.HK)2026 Interim Report - Profit Attributable to Shareholders stood at CNY 47.61 million, YoY decrease of 43.1% ] NewTimeSpace (newtimespace.com) News,August 31, 2026, GOLDEN THROAT(06896.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 280.13 million, decreased by 12.25% YoY

Tag： GOLDEN THROAT 06896.HK NewTimeSpace

09:01

[ China’s Largest Power‑Generation Engine Supplier! Yuchai Marine & Genset Power Refiles for Hong Kong IPO ] Newtimespace News: Guangxi Yuchai Marine and Genset Power Co., Ltd. refiled its listing application with the Hong Kong Stock Exchange on 31 August, with China Merchants Securities (International) and China Galaxy International acting as joint sponsors. According to Frost & Sullivan, the company ranked first in China by sales revenue of power‑generation engines in 2025, and second for medium‑ and high‑speed marine engines over the same period. Its overseas sales surged 120.5% year‑on‑year in the first half of 2026.

Tag： Yuchai Marine IPO file a listing application

08:59

[ CSPC PHARMA (01093.HK): Phase I clinical trial of SYH2092 for weight management initiated in China ] NewTimeSpace News: On 31 August 2026, CSPC PHARMA (01093.HK) announced that the Phase I clinical trial of SYH2092 injection, an amylin receptor agonist for weight management in adults who are overweight or obese, has been formally initiated at the first clinical trial centre in China, following the drug clinical trial approval notice obtained from the National Medical Products Administration in August 2026.

Tag： CSPC PHARMA 01093.HK Clinical Trial

08:57

[ WAI CHUN BIOTEC (00660.HK): Discloses details of Malaysia AI data centre project, formal agreement pending ] NewTimeSpace News: On 31 August 2026, WAI CHUN BIOTEC (00660.HK) disclosed further details at the request of the Stock Exchange on its AI data centre project at the Pahang Aerospace City in Malaysia, which will proceed in two phases with Phase 1 expected to take approximately 12 to 36 months to construct and commission; the MOU is not legally binding except for confidentiality and exclusivity provisions, and a formal agreement has yet to be signed.

Tag： WAI CHUN BIOTEC 00660.HK strategic cooperation

08:55

[ SHEIN-W (00625.HK): Final offer price set at HKD 48.56 per share, trading to commence on 1 September ] NewTimeSpace News: On 31 August 2026, SHEIN-W (00625.HK) announced a final offer price of HKD 48.56 per share for its global offering, with trading to commence on 1 September in board lots of 100 shares; the Hong Kong public offering was 5.63 times subscribed, and net proceeds are approximately HKD 13,214.1 million.

Tag： SHEIN-W 00625.HK IPO Listing

08:51

[ SHIFANG HLDG (01831.HK): Shares of several shareholder companies allegedly transferred without authorisation, trading remains suspended ] NewTimeSpace News: On 31 August 2026, SHIFANG HLDG (01831.HK) announced that shares of several shareholder companies were allegedly transferred without authorisation, with the company seals on the transfer documents visibly different from those on file; the Company has reported the matter to the Hong Kong police, and trading in its shares has been suspended since 24 August and will continue to be suspended.

Tag： SHIFANG HLDG 01831.HK Suspected Theft Suspension

08:46

[ CHAMPION TECH (00092.HK): Auditor may disclaim opinion on FY2026 financial statements, placing terminated ] NewTimeSpace News: On 31 August 2026, CHAMPION TECH (00092.HK) announced that its auditors may disclaim an opinion on the going concern matter in its FY2026 financial statements, with losses expected to be more severe than the same period in 2025, and the placing of up to 84,024,000 new shares was immediately terminated on the same day.

Tag： CHAMPION TECH 00092.HK Termination of Placing

08:24

[ C STRATEGIC TEC (01725.HK): Signs framework agreement to set up JV in digital anti-counterfeiting ] NewTimeSpace News: On 31 August 2026, C STRATEGIC TEC (01725.HK) announced that it signed a strategic cooperation framework agreement with Gaochain to set up a JV in Guangzhou with registered capital of RMB 10 million (51/49 shareholding) in digital anti-counterfeiting and related areas, with the formal establishment still subject to approvals and due diligence.

Tag： C STRATEGIC TEC 01725.HK joint venture

08:22

[ MICROPORT (00853.HK): Delays 2026 interim results, shares and debt securities suspended from 1 September ] NewTimeSpace News: On 31 August 2026, MICROPORT (00853.HK) announced that it cannot publish its 2026 interim results on or before 31 August 2026, and trading in its shares and debt securities will be suspended from 9:00 a.m. on 1 September 2026 pending publication of the interim results.

Tag： MICROPORT 00853.HK Delay

08:20

[ MAN WAH HLDGS (01999.HK): US subsidiary Southern Motion files for Chapter 11 bankruptcy ] NewTimeSpace News: On 31 August 2026, MAN WAH HLDGS (01999.HK) announced that its direct wholly-owned subsidiary Southern Motion, Inc. has filed for Chapter 11 bankruptcy proceedings in the United States amid commercial disputes and operating losses, and the Acquired Group will continue operations until the disputes are resolved.

Tag： MAN WAH HLDGS 01999.HK Bankruptcy Proceedings

08:13

[ FS ANTHRACITE (01738.HK): Delays 2026 interim results, trading may be suspended from 1 September ] NewTimeSpace News: On 31 August 2026, FS ANTHRACITE (01738.HK) announced a delay in publishing its 2026 interim results, now expected on 30 October 2026, with trading in its shares potentially suspended from 1 September if the results are not published on time.

Tag： FS ANTHRACITE 01738.HK Delay

Scan QR Code

Download App